Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

but the impact of nasal continuous positive airway pressure (CPAP) therapy is unclear. Methods: We performed a long-term follow-up study of 168 patients with OSAS who had begun receiving CPAP ...

He was on an oxygen cylinder to help him breathe attached to a nasal cannula - a tube through the nose. A health care assistant took him to the toilet with the cylinder and helped him to a seat.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato ... include temporarily increased blood pressure, mental haziness, and bladder ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...